US EditionMasimo sues US Customs over Apple Watch blood oxygen return
Masimo alleges the U.S. Customs and Border Protection reversed its prior ban without notice, allowing Apple to re-enable blood oxygen monitoring, which Masimo claims infringes its patents and harms competition.
- Masimo, a medical technology company, sued U.S. Customs and Border Protection over its decision to allow Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the two companies.
- Masimo claims that Customs improperly reversed its previous decision without notifying Masimo, allowing Apple to reintroduce blood-oxygen reading to its watches.
- Masimo argues that Customs' decision effectively nullified an International Trade Commission order against Apple, and the company is seeking a court order to block the decision and reinstate the original ruling.
Insights by Ground AI
Does this summary seem wrong?
37 Articles
37 Articles
Masimo Sues US Customs Over Approval of Apple Watch Imports
·New York, United States
Read Full Article
Masimo sues US Customs over approval of Apple Watch imports
Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies.
·United Kingdom
Read Full ArticleCoverage Details
Total News Sources37
Leaning Left6Leaning Right1Center7Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 43%
C 50%
Factuality
To view factuality data please Upgrade to Premium
